Skip to main content

What the FDA labels say about taking them together

Furosemide and ramipril

Neither FDA label names the other in its interaction, contraindication or warning sections. A label lists the interactions its studies and reports found; it is not a complete list, so ask a pharmacist before combining medicines. Labels read October 8, 2026.

Check it at the source: the furosemide FDA label on DailyMed (effective September 30, 2025, Validus Pharmaceuticals LLC); the ramipril FDA label on DailyMed (effective August 24, 2026, Lupin Pharmaceuticals, Inc.).

What does the furosemide label say about ramipril?

Furosemide's label does not name ramipril itself; it warns about its class (ACE inhibitors):

Furosemide label, drug interactions

LASIX combined with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers may lead to severe hypotension and deterioration in renal function, including renal failure.

Furosemide label, drug interactions

An interruption or reduction in the dosage of LASIX, angiotensin-converting enzyme inhibitors, or angiotensin receptor blockers may be necessary.

Source: FDA drug label (Lasix), Validus Pharmaceuticals LLC, effective September 30, 2025 (SPL set 2c9b4d8f-0770-482d-a9e6-9c616a440b1a), via openFDA; the full label on DailyMed

What does the ramipril label say about furosemide?

Ramipril's label (effective August 24, 2026) does not name furosemide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Ramipril), Lupin Pharmaceuticals, Inc., effective August 24, 2026 (SPL set a8cdec12-81d1-4ef4-82c0-d05d93c37a07), via openFDA; the full label on DailyMed

A pharmacist or prescriber can say whether these two medicines suit one person together; PlainMeds does not grade interactions.

Both medicines on the record

52Furosemide generic labelers
17Ramipril generic labelers
FurosemideRamipril
Labeled forHeart failure, High blood pressure, Edema (fluid retention)High blood pressure, Heart attack and coronary artery disease
Boxed warningNoYes
Pharmacy cost (NADAC)$0.490 per mL 20 mg/2 mL vial$0.0707 per capsule 10 mg capsule
Shortage nowIn shortageNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?